Table 1.
Clinical and laboratory results of subjects with lichen planus and controls
| Parameter | Patient group | Control group | P-value | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Number of subjects, n | 55 | 48 | |||||||||
| Gender: | Male | 37 (49%) | 23 (48%) | 0.906 | |||||||
| Female | 28 (51%) | 25 (52%) | |||||||||
| Types of lichen planus: | Anulary | 3 (5.5%) | |||||||||
| Hypetrophic | 2 (3.6%) | ||||||||||
| Genaralized | 30 (54.5%) | ||||||||||
| Localized | 20 (36.4%) | ||||||||||
| Involvement site: | Upper extremity | 45 (33.3%) | |||||||||
| Lower extremity | 42 (31.1%) | ||||||||||
| Trunk | 31 (22.8%) | ||||||||||
| Plantar | 6 (4.5%) | ||||||||||
| Palmary | 3 (2.3%) | ||||||||||
| Inguinal | 5 (3.8%) | ||||||||||
| Palpebral | 2 (1.5%) | ||||||||||
| Axillary | 1 (0.7%) | ||||||||||
| Involvement of nail: | Yes | 27 (49%) | |||||||||
| No | 28 (51%) | ||||||||||
| Involvement of mouth: | Yes | 27 (49%) | |||||||||
| No | 28 (51%) | ||||||||||
| Parameter | Mean | ± SD | Median | Range | Mean | ± SD | Median | Range | P-value | ||
| Age [years] | 46.1 | ±12.6 | 46 | 18–80 | 44.7 | ±11.9 | 43 | 19–74 | 0.577 | ||
| Disease duration time [months] | 10.8 | ±18.2 | 6 | 0.5–96 | |||||||
| BSA (%) | 17.3 | ±16.1 | 13 | 1–80 | |||||||
| C-reactive protein [mg/dl] | 8.7 | ±8.3 | 5.7 | 1–38 | 3.7 | ±3.2 | 3 | 1–22 | < 0.0001 | ||
| Erythrocyte sedimentation rate [mm/h] | 19.2 | ±10.9 | 17 | 5–51 | 11.9 | ±6.2 | 11 | 2–22 | < 0.0001 | ||
| White blood cell [× 103/µl] | 7.6 | ±1.7 | 7.4 | 5.1–11 | 7.1 | ±1.3 | 7.1 | 5.1–11 | 0.058 | ||
| Neutrophile [× 103/µl] | 4.8 | ±1.4 | 4.4 | 2.8–8.6 | 3.5 | ±0.8 | 3.4 | 2.2–5.9 | < 0.0001 | ||
| Lymphocyte [× 103/µl] | 2.1 | ±0.6 | 1.9 | 1–3.5 | 2.7 | ±0.6 | 2.7 | 1.7–4.3 | < 0.0001 | ||
| Neutrophile/lymphocyte ratio | 2.5 | ±1.1 | 2.3 | 1.2–7.3 | 1.4 | ±0.4 | 1.3 | 0.8–2.7 | < 0.0001 | ||
| Platelets [× 103/µl] | 242 | ±55.7 | 233 | 152–368 | 236 | ±65.5 | 224 | 140–481 | 0.292 |
BSA – body surface area, SD – standard deviation.